Somatostatin analogue in short term management of hyperinsulinism.
Open Access
- 1 December 1988
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 63 (12) , 1493-1494
- https://doi.org/10.1136/adc.63.12.1493
Abstract
Five infants with hypoglycaemia due to hyperinsulinism were treated for between three and 11 days with a somatostatin analogue, which raised the mean blood glucose concentration and lowered the glucose requirements in all. Somatostatin analogue appears to be useful in the short term management of these patients.This publication has 6 references indexed in Scilit:
- Short-Term Management of Nesidioblastosis Using the Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1987
- EFFECT OF SOMATOSTATIN INFUSION ON INTERMEDIARY METABOLISM AND ENTERO‐INSULAR HORMONE RELEASE IN INFANTS WITH HYPERINSULINAEMIC HYPOGLYCAEMIAActa Paediatrica, 1981
- The Effect of Somatostatin Analogs on Secretion of Growth, Pancreatic, and Gastrointestinal Hormones in ManJournal of Clinical Endocrinology & Metabolism, 1981
- Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia.Archives of Disease in Childhood, 1981
- Hypoglycemia of Infancy and NesidioblastosisNew England Journal of Medicine, 1977
- Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic RatsDiabetes, 1963